MyBlueDotsBreast Cancer Canada’s Path for 2025: Prioritizing Early Detection, Timely Access, and Breakthrough Research MyBlueDots8 months ago01 mins TORONTO–(BUSINESS WIRE)–Breast Cancer Canada is committed to its mission to advance breast cancer research, advocacy, and equitable access in 2025. Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products